Liontrust ( I hold, have bought and sold in the past, bought again after last figures-before the STJ news) has increased it's stake in Impax today by 1.0%. They originally got involved when BNP Paribas sold part of their stake at 510p and ended up with an 8.5% holding

This was back in 2020.

They now hold 12.26% following recent purchases.

I would suggest that Impax and Liontrust merged would create a stronger, and more risk diversified Investment management group.

Will this happen- I have no idea. But in my opinion the sell off of Impax has been well overdone. I am not convinced the sectors Impax invest in will remain unpopular for long.

Equity Development, whilst paid to research companies, still have a downgraded TSP of 600p. Whilst I am always careful of a these views, they would not be in business if they were consistently misleading investors with research. Note here.

Whether the dividend will be maintained is I assume doubtful.

I am sure others will disagree regarding Impax- hope there will be a debate. I am considering buying more.

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here